Recent studies in wild-type mice with colitis treated with neutralizing antibodies indicate that depending on the disease, single or dual blockade of M-CSF-1 and IL-34 is needed for inhibiting mucosal inflammation consistent with the concordant tissue-specific expression of both cytokines in inflamed gut (43). The gene discussed is IL34; the disease is colitis.